Biofrontera Historical Financial Ratios
| BFRI Stock | USD 0.90 0.04 4.65% |
Biofrontera is presently reporting on over 89 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 1.4 K or Days Sales Outstanding of 71.37 will help investors to properly organize and evaluate Biofrontera financial condition quickly.
Biofrontera |
About Biofrontera Financial Ratios Analysis
BiofronteraFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Biofrontera investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Biofrontera financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Biofrontera history.
Biofrontera Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Biofrontera stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Biofrontera sales, a figure that is much harder to manipulate than other Biofrontera multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Inventory Turnover
A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.Most ratios from Biofrontera's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Biofrontera current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biofrontera. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Biofrontera Stock please use our How to Invest in Biofrontera guide.As of now, Biofrontera's Book Value Per Share is increasing as compared to previous years. The Biofrontera's current PB Ratio is estimated to increase to 1,424, while Free Cash Flow Yield is projected to decrease to (0).
| 2022 | 2023 | 2024 | 2025 (projected) | Payables Turnover | 11.88 | 1.96 | 9.62 | 6.74 | Days Of Inventory On Hand | 172.3 | 228.24 | 135.86 | 230.6 |
Biofrontera fundamentals Correlations
Click cells to compare fundamentals
Biofrontera Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Biofrontera fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Price To Sales Ratio | 2.71 | 5.34 | 0.68 | 0.13 | 161.19 | 169.25 | |
| Ptb Ratio | 8.78 | 11.34 | 0.81 | 0.89 | 1.4K | 1.4K | |
| Days Sales Outstanding | 63.69 | 57.31 | 94.27 | 55.3 | 52.01 | 71.37 | |
| Book Value Per Share | 10.05 | 13.26 | 22.59 | 3.1 | 8.04E-4 | 8.44E-4 | |
| Free Cash Flow Yield | (0.24) | (0.21) | (0.84) | (5.81) | (0.00171) | (0.001795) | |
| Operating Cash Flow Per Share | (21.33) | (31.24) | (15.33) | (16.1) | (0.001862) | (0.001955) | |
| Pb Ratio | 8.78 | 11.34 | 0.81 | 0.89 | 1.4K | 1.4K | |
| Ev To Sales | 2.29 | 4.32 | 0.12 | 0.24 | 161.16 | 169.22 | |
| Free Cash Flow Per Share | (21.33) | (31.25) | (15.36) | (16.1) | (0.001864) | (0.001957) | |
| Roic | (0.43) | (0.66) | (0.76) | (1.57) | (1.62) | (1.7) | |
| Inventory Turnover | 1.28 | 2.86 | 2.12 | 1.6 | 2.69 | 1.56 | |
| Net Income Per Share | (18.94) | (44.1) | (0.61) | (13.02) | (0.003219) | (0.00338) | |
| Days Of Inventory On Hand | 285.49 | 127.7 | 172.3 | 228.24 | 135.86 | 230.6 | |
| Payables Turnover | 5.99 | 19.36 | 11.88 | 1.96 | 9.62 | 6.74 | |
| Sales General And Administrative To Revenue | 0.96 | 1.54 | 1.25 | 1.11 | 1.0 | 0.95 | |
| Cash Per Share | 13.93 | 28.7 | 26.26 | 0.92 | 0.00107 | 0.001017 | |
| Pocfratio | (4.14) | (4.81) | (1.2) | (0.17) | (585.47) | (556.2) | |
| Interest Coverage | (2.88) | (75.15) | (114.77) | (37.79) | 8.46 | 8.88 | |
| Pfcf Ratio | (4.14) | (4.81) | (1.19) | (0.17) | (584.9) | (555.66) | |
| Days Payables Outstanding | 60.95 | 18.85 | 30.72 | 186.35 | 37.94 | 36.04 | |
| Income Quality | 1.13 | 0.71 | 25.31 | 1.24 | 0.58 | 0.55 | |
| Roe | (1.89) | (3.33) | (0.0268) | (4.2) | (4.01) | (4.21) | |
| Ev To Operating Cash Flow | (3.48) | (3.9) | (0.22) | (0.33) | (585.38) | (556.11) | |
| Pe Ratio | (4.66) | (3.41) | (30.29) | (0.21) | (338.58) | (321.65) | |
| Ev To Free Cash Flow | (3.48) | (3.89) | (0.22) | (0.33) | (584.81) | (555.57) | |
| Intangibles To Total Assets | 0.16 | 0.0648 | 0.0596 | 0.0941 | 0.001584 | 0.001504 | |
| Net Debt To E B I T D A | 1.08 | 0.67 | (16.98) | (0.22) | 0.0571 | 0.06 | |
| Current Ratio | 4.43 | 3.36 | 2.06 | 1.28 | 1.72 | 2.72 | |
| Tangible Book Value Per Share | 3.38 | 9.22 | 19.72 | 1.4 | 7.97E-4 | 8.37E-4 | |
| Receivables Turnover | 5.73 | 6.37 | 3.87 | 6.6 | 7.02 | 4.67 | |
| Shareholders Equity Per Share | 10.05 | 13.26 | 22.59 | 3.1 | 8.04E-4 | 8.44E-4 | |
| Graham Net Net | (7.27) | (14.35) | 9.36 | (8.01) | (8.07E-4) | (8.48E-4) |
Currently Active Assets on Macroaxis
When determining whether Biofrontera offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biofrontera's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biofrontera Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biofrontera Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biofrontera. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Biofrontera Stock please use our How to Invest in Biofrontera guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biofrontera. If investors know Biofrontera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biofrontera listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 1.16 | Revenue Per Share | Quarterly Revenue Growth 0.013 | Return On Assets | Return On Equity |
The market value of Biofrontera is measured differently than its book value, which is the value of Biofrontera that is recorded on the company's balance sheet. Investors also form their own opinion of Biofrontera's value that differs from its market value or its book value, called intrinsic value, which is Biofrontera's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biofrontera's market value can be influenced by many factors that don't directly affect Biofrontera's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biofrontera's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biofrontera is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biofrontera's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.